Avacopan for the Treatment of ANCA-Associated Vasculitis

Overview of attention for article published in New England Journal of Medicine, February 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 30 news outlets
blogs: 6 blogs
policy: 2 policy sources
twitter: 393 X users
patent: 6 patents
facebook: 4 Facebook pages

wikipedia: 4 Wikipedia pages
reddit: 1 Redditor
f1000: 1 research highlight platform
guideline: 8 clinical guideline sources
bluesky: 5 Bluesky users
podcasts: 6 podcasts

Readers on

mendeley: 627 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

SELECTION AND CHARACTERIZATION OF A PEPTIDE-BASED COMPLEMENT ACTIVATOR

Grant NL-2037390-B1

Netherlands

13 Oct 2025

PEPTIDE-BASED COMPLEMENT ACTIVATOR

Application WO-2025210126-A1

World Intellectual Property Organisation (WIPO)

09 Oct 2025

CD19-directed chimeric antigen receptors and uses thereof in immunotherapy

Grant US-12398187-B2

United States of America

26 Aug 2025

FACTOR B INHIBITORS FOR TREATMENT OF ANCA-ASSOCIATED VASCULITIS

Application WO-2025172910-A1

World Intellectual Property Organisation (WIPO)

21 Aug 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.